Teva Pharmaceutical Industries | TEVA - Pre Tax Profit


Teva Pharmaceutical Industries reported $91M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Aspen Pharmacare ZAR 1.4B 51M Jun/2024
Cipla INR 11.69B 6.85B Dec/2025
Dr.Reddys Laboratories INR 15.68B 2.38B Dec/2025
Guangzhou Baiy CNY -494.18M 1.59B Dec/2025
Jiangsu Hengrui CNY 2.3B 934.54M Dec/2025
Kalbe Farma IDR 877.87B 315.23B Sep/2025
Richter Gedeon HUF 78.56B 32.66B Dec/2024
Sh Fosun Pharma CNY 1.12B 252.08M Sep/2025
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025